community health center
Showing 9976 - 10000 of >10,000
PTSD Trial in San Antonio (Intensive Outpatient Program - Prolonged Exposure)
Completed
- Posttraumatic Stress Disorder
- Intensive Outpatient Program - Prolonged Exposure
-
San Antonio, TexasUniversity of Texas Health Science Center at San Antonio
Mar 21, 2022
Human Papilloma Virus, Cervical Cancer, Oropharyngeal Cancer Trial run by the NCI (M7824)
Active, not recruiting
- Human Papilloma Virus
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 28, 2022
Pulmonary Disease Due to Mycobacteria (Diagnosis) Trial in Worldwide (Amikacin, Tigecycline, Imipenem)
Recruiting
- Pulmonary Disease Due to Mycobacteria (Diagnosis)
- Amikacin
- +13 more
-
South Brisbane, Queensland, Australia
- +36 more
Sep 12, 2022
HIV, Hematologic Malignancies Trial run by the National Cancer Institute (NCI) (RIC, GVHD prophylaxis, allo HCT)
Not yet recruiting
- HIV
- Hematologic Malignancies
- RIC
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Atlanta (drug, behavioral, other)
Not yet recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Psilocybine
- +3 more
-
Atlanta, Georgia
- +1 more
Aug 16, 2022
Frailty Trial in Hamilton (Socialization, Virtual Group Exercise, Nutrition Consult and Protein Supplementation)
Completed
- Frailty
- Socialization
- +3 more
-
Hamilton, Ontario, CanadaMcMaster University - Hamilton Health Sciences (St. Peter's Site
Mar 4, 2022
Post-Operative Atrial Fibrillation Trial in United States (AtriClip® Gillinov-Cosgrove™ LAA Exclusion Systems, Anticoagulation
Completed
- Post-Operative Atrial Fibrillation
- AtriClip® Gillinov-Cosgrove™ LAA Exclusion Systems
- Anticoagulation Therapy
-
San Diego, California
- +21 more
Oct 28, 2021
Elderly, Functional Status Trial in Canada (Exercise program)
Unknown status
- Elderly
- Functional Status
- Exercise program
-
Calgary, Alberta, Canada
- +5 more
Jun 18, 2019
Post-acute COVID-19 Syndrome Trial in Russian Federation (Prospekta, Placebo)
Completed
- Post-acute COVID-19 Syndrome
- Prospekta
- Placebo
-
Belgorod, Russian Federation
- +31 more
Jan 20, 2023
Sexually Transmitted Infections Trial in Fayetteville, Tacoma (STI/HIV Intervention Behavioral Intervention Program)
Recruiting
- Sexually Transmitted Infections
- STI/HIV Intervention Behavioral Intervention Program
-
Fayetteville, North Carolina
- +1 more
Jan 20, 2023
Metastatic Castration Resistant Prostate Cancer Trial in United States (LAVA-1207)
Recruiting
- Metastatic Castration Resistant Prostate Cancer
- LAVA-1207
-
Tampa, Florida
- +3 more
Nov 18, 2022
Breast Cancer Trial in Canada, United States (trastuzumab, carboplatin, paclitaxel)
Completed
- Breast Cancer
- trastuzumab
- +2 more
-
Scottsdale, Arizona
- +24 more
Oct 4, 2019
Leukemia, Myeloid, Acute Trial in Worldwide (Oral Azacitidine, Placebo)
Active, not recruiting
- Leukemia, Myeloid, Acute
- Oral Azacitidine
- Placebo
-
Phoenix, Arizona
- +247 more
Jan 13, 2023
Cognitive Decline, Cognitive Impairment, Mild Trial in Singapore (Multi-domain intervention)
Completed
- Cognitive Decline
- Cognitive Impairment, Mild
- Multi-domain intervention
-
Singapore, SingaporeGeriatric Education And Research Institute
Jun 18, 2020
Multiple Myeloma Trial in Worldwide (Daratumumab, Bortezomib, Lenalidomide)
Active, not recruiting
- Multiple Myeloma
- Daratumumab
- +3 more
-
Whittier, California
- +113 more
Jan 17, 2023
Stanford Five-City Multifactor Risk Reduction Study
Completed
- Cardiovascular Diseases
- +6 more
- (no location specified)
Feb 12, 2021
HCC, Early Stage HCC Trial in Leiden (Quirem Medical Holmium-166 radioembolization microspheres)
Completed
- HCC
- Early Stage HCC
- Quirem Medical Holmium-166 radioembolization microspheres
-
Leiden, Zuid-Holland, NetherlandsLeiden University Medical Center
Mar 17, 2021
Thyroid Eye Disease, Graves' Orbitopathy Trial in Germany, Italy, United States (Teprotumumab, Placebo)
Completed
- Thyroid Eye Disease
- Graves' Orbitopathy
- Teprotumumab
- Placebo
-
Beverly Hills, California
- +13 more
Jan 31, 2022
Financing Strategies of Influenza Vaccination in China
Completed
- Influenza Vaccines
- +4 more
- No intervention
-
Beijing, Beijing, China
- +2 more
Jan 7, 2022
Atrial Fibrillation (AF), Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation Trial in United States
Recruiting
- Atrial Fibrillation (AF)
- +2 more
- AtriCure CryoICE & AtriClip LAA Exclusion
-
Los Angeles, California
- +16 more
Mar 1, 2022
HIV Trial in United States (VRC-HIVDNA009-00-VP (Gag-Pol-Nef-multiclade-Env) with adjuvant VRC-ADJDNA004-IL2-VP)
Completed
- HIV Infections
- VRC-HIVDNA009-00-VP (Gag-Pol-Nef-multiclade-Env) with adjuvant VRC-ADJDNA004-IL2-VP
-
Baltimore, Maryland
- +6 more
Oct 13, 2021
Coronary Artery Disease (CAD) Trial in Worldwide (PET MPI, SPECT MPI, Pharmacological stress agents)
Completed
- Coronary Artery Disease (CAD)
- PET MPI
- +2 more
-
Birmingham, Alabama
- +52 more
May 18, 2022
Thyroid Eye Disease Trial in Germany, Italy, United States (Teprotumumab)
Completed
- Thyroid Eye Disease
- Teprotumumab
-
Beverly Hills, California
- +12 more
Dec 9, 2021
Cancer Survivor Trial in Albuquerque (home-based, mentored vegetable gardening program)
Completed
- Cancer Survivor
- home-based, mentored vegetable gardening program
-
Albuquerque, New MexicoUniversity of New Mexico
Mar 22, 2021
Aducanumab-avwa in Alzheimer's Disease in the US
Terminated
- Alzheimers Disease
-
Chula Vista, California
- +21 more
Jun 16, 2022